Cerus signs INTERCEPT platelet agreement with Sweden’s largest blood product supplier
Cerus announced that the Karolinska University Hospital in Stockholm, has signed a three-year agreement to purchase the INTERCEPT Blood System for platelets. In addition to the three-year base term, the agreement allows for automatic annual extensions for an additional two years. February 27, 2015